Abstract:Recent evidence has suggested that miRNA is implicated in the immune response of allergic and inflammatory diseases. However, little is known about its role in the mechanism that underlies the establishment of pro-allergic DCs in allergic rhinitis is not fully understood. This study assessed whether and how microRNA (miR)-106b regulates the pro-allergic properties of DCs upon allergen stimulation in vitro. Bone marrow-derived dendritic cells (BMDCs) were generated and stimulated with ovalbumin (OVA) to identify the miRNA expression profile. After transfection with miR-106b mimics and inhibitors OVA-activated BMDCs were further evaluated for surface marker expression using flow cytometry, cytokine production using ELISA and subsequent effects on Th2 cell polarisation using flow cytometry. Moreover, the upstream controllers and potential target proteins of miR-106b were examined in a western blot analysis. Results showed that MiR-106b expression was significantly inhibited in activated BMDCs upon OVA stimulation (p<0.05). Surface marker expression (e.g., MHC class II, CD80 and CD86) was significantly upregulated after the transfection of an miR-106b inhibitor (p<0.05), and the proportion of GATA-3+ T cells was significantly increased among CD4+ T cells that were cocultured with miR-106b inhibitor-pretreated BMDCs (p<0.05). Conversely, IL-12 production from OVA-activated BMDCs and the proportion of T-bet+ T cells increased significantly in a coculture of CD4+ T cells and miR-106b mimics-transfected BMDCs (p<0.05). The early growth response (Egr)-2 was identified via luciferase reporter assays as a target gene of miR-106b, and significant Egr-2 upregulation was observed in OVA-activated BMDCs following transfection with a miR-106b inhibitor (p<0.05). In conclusion, our results suggest that miR-106b negatively regulates the pro-allergic properties of BMDCs and subsequent Th2 polarisation upon OVA stimulation and might represent a promising therapeutic target for allergic inflammation.

MicroRNA-146a and Microrna-146B Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins.

Mir-146a and Mir-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting of TRAF6 and IRAK1

Microrna-181A Represses Ox-Ldl-stimulated Inflammatory Response in Dendritic Cell by Targeting C-Fos

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Mir-221 and Mir-155 Regulate Human Dendritic Cell Development, Apoptosis, and Il-12 Production Through Targeting of P27(Kip1), Kpc1, and Socs-1

Loss of miR-146a skews the dendritic cell milieu in favor of CD8a+CD103+ cross-presenting migratory dendritic cells and reduces production of IL-27

MicroRNAs Regulate Dendritic Cell Differentiation and Function

MicroRNA-146a Regulates the Maturation Process and Pro-Inflammatory Cytokine Secretion by Targeting CD40L in Oxldl-Stimulated Dendritic Cells.

MicroRNA-148/152 Impair Innate Response and Antigen Presentation of TLR-triggered Dendritic Cells by Targeting CaMKIIα.

miR-146a −/− deficiency in the DC compartment results in increased effector phenotype CD4+ and CD8+ T cells in response to LCMV infection

Identification of Resting and Type I Ifn-Activated Human Nk Cell Mirnomes Reveals Microrna-378 and Microrna-30e As Negative Regulators of Nk Cell Cytotoxicity

TNF-α Mrna is Negatively Regulated by Microrna-181A-5p in Maturation of Dendritic Cells Induced by High Mobility Group Box-1 Protein

Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway.

MicroRNA-155 Modulates the Interleukin-1 Signaling Pathway in Activated Human Monocyte-Derived Dendritic Cells.

Role of microRNAs in the Regulation of Dendritic Cell Generation and Function

MiR-34a Promotes DCs Development and Inhibits Their Function on T Cell Activation by Targeting WNT1

MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis.

MiR-200b Modulates the Properties of Human Monocyte-Derived Dendritic Cells by Targeting WASF3

Dendritic Cell-Associated Mirnas Are Modulated Via Chromatin Remodeling in Response to Different Environments.

Blockade of miR-142-3p promotes anti-apoptotic and suppressive function by inducing KDM6A-mediated H3K27me3 demethylation in induced regulatory T cells

Microrna-106b Regulates Pro-Allergic Properties of Dendritic Cells and Th2 Polarisation by Targeting Early Growth Response-2 in Vitro